FC
RVMD icon

FORA Capital’s Revolution Medicines RVMD Stock Holding History

FORA Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
15,218
-2,139
-12% -$216K 0.11% 192
2025
Q4 		$1.37M Buy
17,357
+10,988
+173% +$720K 0.17% 163
2025
Q3 		$297K Buy
+6,369
New +$249K 0.05% 373
2021
Q3 		– Sell
-2,581
Closed -$82K – 773
2021
Q2 		$82K Buy
+2,581
New +$90.1K 0.02% 632
2021
Q1 		– Sell
-4,488
Closed -$178K – 1050
2020
Q4 		$178K Buy
+4,488
New +$177K 0.03% 536

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FORA Capital's RVMD Position: Q1 2026 in Review

FORA Capital reduced its Revolution Medicines (RVMD) stake by 12% in Q1 2026, selling an estimated $216K and leaving 15,218 shares worth $1.48M. The position accounts for 0.11% of the portfolio, ranked #192.

FORA Capital first reported a position in RVMD in Q4 2020 and has held it in 5 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • FORA Capital held 15,218 shares of Revolution Medicines worth $1.48M as of Q1 2026.
  • FORA Capital sold 2,139 Revolution Medicines shares in Q1 2026, an estimated $216K.
  • Revolution Medicines made up 0.11% of FORA Capital's portfolio in Q1 2026, its #192 holding.
  • FORA Capital first reported a position in Revolution Medicines in Q4 2020 and has held it in 5 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.